RankingsPricing
  1. US-listed companies
  2. CVS HEALTH Corp
  3. Raw

CVS HEALTH CorpCVS

Market cap
$99B
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2010		Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
Proceeds from Customers-97,688113,205114,993132,406148,954172,310176,594186,519248,393264,327284,219313,662345,464357,995
Cash paid for inventory, prescriptions dispensed and health services rendered--------148,821---189,766208,848197,726
Insurance benefits paid--------7,057---69,72884,097109,464
Cash paid to other suppliers and employees13,77813,63513,64314,29515,34414,16215,55015,34817,23428,93229,76331,65232,66234,73538,821
Interest and investment income received--------6449558947431,0261,5841,735
Interest paid-------1,0722,8032,9542,9042,4692,2392,4182,909
Income taxes paid-------2,9092,3832,7172,9293,1954,1163,5241,703
Net cash provided by operating activities4,7795,8566,6715,7838,1378,41210,0698,0078,86512,84815,86518,26516,17713,4269,107
Proceeds from sales and maturities of investments--------8177,0496,4677,2466,7297,72910,353
Purchases of investments--------6927,5349,6399,9637,7469,04315,191
Purchases of property and equipment2,0051,8722,0301,9842,1362,3672,2241,9182,0372,4572,4372,5202,7273,0312,781
Acquisitions (net of cash and restricted cash acquired)1771,4413784152,43911,4755391,28742,22644486614613916,61295
Proceeds from Divestiture of Businesses, Net of Cash Divested--------832-840--1,249--
Other---------21-42--122-85-68-101
Net cash used in investing activities-1,640-2,410-1,849-1,835-4,045-13,420-2,470-2,932-43,285-3,339-5,534-5,261-5,047-20,889-7,613
Commercial paper borrowings (repayments), net-------------2001,919
Proceeds from Other Short-Term Debt-------------5,000-
Repayment of short-term loan-------------5,000-
Proceeds from issuance of long-term debt9911,4631,2393,9641,48314,8053,455-44,3433,7369,958987-10,8987,913
Repayments of long-term debt2,1032,1221,718-3,1002,9025,943-5,5228,33615,63110,2544,2113,1664,773
Repurchase of common stock1,5003,0014,3303,9764,0015,0014,4614,361----3,5002,0123,023
Dividends paid4796748291,0971,2881,5761,8402,0492,0382,6032,6242,6252,9073,1323,373
Proceeds from Stock Options Exercised285431836500421299224329242210264549551277361
Payments for taxes related to net share settlement of equity awards-------719711288168370181185
Other--9----3-5-11--27155-79-20126
Net cash provided by (used in) financing activities-2,798-3,460-4,860-1,237-5,6945,006-6,689-6,75136,819-7,850-8,155-11,356-10,5162,683-1,135
Net increase (decrease) in cash, cash equivalents and restricted cash--------2,3951,6592,1761,648614-4,780359
Net income3,4243,4573,8754,5924,6445,2395,3196,623-5966,6317,1927,8984,1658,3684,586
Depreciation and amortization-------2,4792,7184,3714,4414,5124,2474,3664,597
Loss on assets held for sale------------2,533349-
Stock-based compensation150135132141165230222234280453400484447588540
Restructuring Costs, Asset Impairment Charges--------------840
Gain on sale of subsidiaries------------475--
Gain on early extinguishment of debt---348--521--643---79-1,440-452--491
Deferred income taxes--------87-654-570-428-2,075-676-572
Other items--------53-339-264-72390-332-416502
Accounts receivable, net-5327483872,2107371,5942439411,1392,1581,5102,7032,9716,2601,301
Inventories352-607858-127701,1417425141,1531,075973-7351,435-1,233102
Other assets-4999135-9-243-3-614-364356651038
Increase (Decrease) in Accounts Payable-401,1281,1471,0241,7422,8342,1891,7102,4893,5502,7692,8984,2603,6182,335
Increase (Decrease) in Insurance Liabilities---------471320-2311691,2473942,757
Other liabilities----13-1042381651,4762,7402,8526,4681,540-3,542
Net cash provided by operating activities4,7795,8566,6715,7838,1378,41210,0698,0078,86512,84815,86518,26516,17713,4269,107